The aim of the investigation was to provide a rationale for refusal from antibacterial therapy in the hypoplastic variant of chronic endometritis.
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Treatment of the Hypoplastic Variant of Chronic Endometritis: Arguments Against Antibacterial Therapy
At present there are two approaches to solving the problem of chronic endometritis treatment [1] [2] [3] [4] . Some researchers consider this disease to be just an inflammatory reaction requiring administration of antibiotic therapy [2, 3, 5, 6] , others look at chronic endometritis as an autoimmune process, in which using antibiotics is irrational [7] [8] [9] .
However, it is beyond argument that chronic endometritis is mostly diagnosed in women with reproductive failures (habitual fetal loss, infertility, repeated IVF and ET failures), therefore, the necessity to reveal and manage the disease at the preconception period becomes a relevant objective in modern reproductive medicine [6, 10] .
The hypoplastic variant of chronic endometritis with endometrial thickness in "the implantation window" remaining only 8 mm is known to present a major difficulty for restoration of the endometrium. The literature [3, 4, 9] provides data on the attempts to restore the endometrium by introducing immunomodulators, stem cells and by means of physiotherapy [2, 5] . The authors have studied the possibilities of managing the hypoplastic variant of chronic endometritis without antibacterial therapy.
The aim of the investigation was to assess the efficacy of combined use of immunomodulators and a phlebotonic for treatment of the hypoplastic variant of chronic endometritis and to provide a rationale for refusal from antibacterial therapy. Materials and Methods. There were examined and treated 116 patients with the hypoplastic variant of chronic endometritis, whose medical history presented reproductive failures (habitual fetal loss, infertility, repeated IVF and ET attempts). The age of the women under study amounted to 26-41 years with the mean of 31.3±4.7 years. The diagnosis of chronic endometritis was established morphologically. To identify the variant of endometritis all the patients underwent pelvic ultrasound, Doppler imaging was applied to measure the blood flow. Besides, there was performed hysteroscopic, immunohistochemical and bacteriological examination of the endometrium, the parameters of systemic and local immunity were also assessed.
The study complies with the Declaration of Helsinki (adopted in June 1964 (Helsinki, Finland) and revised in October 2000 (Edinburgh, Scotland)) and was performed following approval by the Ethic Committee of Nizhny Novgorod State Medical Academy. Written informed consent was obtained from every patient.
The study was carried out in two stages. At the first stage, the patients underwent bacteriological examination of the uterine cavity contents, the parameters of systemic and local immunity, there were studied Doppler imaging and sonographic markers of the hypoplastic variant of chronic endometritis.
Based on the obtained data convincingly showing that the hypoplastic variant of chronic endometritis has an autoimmune origin, we refused from antibacterial therapy.
To prove out this decision and compare treatment outcomes with the results of conventional therapy the patients were divided into two groups (the second stage): the main group (n=84) and the control (n=32). In the main group the patients were treated for the hypoplastic variant of chronic endometritis without antibacterial therapy. Complex therapy included human placenta hydrolysate (laennec) used as an immunomodulator simultaneously with phlebotonics (diosmin 600). laennec was administered in the dose of 4 ml in 200 ml of normal saline solution by intravenous drop infusion once in 2 days, the treatment course consisting of 10 infusions. Diosmin 600 (Phlebodia 600) was used according to the conventional scheme: 1,200 mg per day orally for 21 days.
The control group comprised 32 women with the hypoplastic variant of chronic endometritis, who received conventional antibiotic therapy and phlebotonics (diosmin 600).
On completing the therapy, the endometrial cell composition (CD3 The obtained data were statistically processed using applied software Microsoft Excel with calculating the arithmetic mean M and standard error of mean m. The significance of differences in compared series was evaluated using Student's t-test and accepted at 5% significance level.
Results and Discussion. At the first stage all obtained findings were analyzed. Bacteriological examination of the uterine cavity contents of all patients with chronic endometritis revealed that only 2.4% of samples were positive for bacteria, while 97.6% of samples appeared to be sterile. Our findings are completely consistent with the research data obtained by Carr et al. [8] , who consider chronic endometritis to be an aseptic autoimmune inflammation.
The endometrial cell composition (Table 1) changes concerned IgG content that proved to be increased by 42.5% (р<0.05), which also spoke of the autoimmune character of the inflammatory process (Table 2) . Pelvic ultrasound examination on day 21-22 of the menstrual cycle revealed that endometrial thickness in all the patients was less than normative values (p<0.05) and averaged 5.1±1.2 mm. When performing Doppler imaging, failure to visualize end branches of the spiral arteries was reported in 93.4% of women from this group, which we considered pathognomonic just for the hypoplastic variant of chronic endometritis (р<0.01).
Thus, given the results of all examinations performed, there was no reason to administer antibiotic therapy in this group of women. The same data conclusively showed that the first-line treatment should be that normalizing the blood flow in the myometrium and endometrium and stabilizing the immune system.
At the second stage there was made a decision to refuse from antibiotics in treatment of a number of women (n=84) and compare the obtained results with the control group (n=32) where conventional therapy was used. Phlebotonics diosmin 600 was used simultaneously with an immunomodulator (human placenta hydrolysate: laennec).
The conducted treatment results showed that none of the therapy methods led to significant changes in the endometrial cell composition (p>0.05), though a tendency towards increase in CD3 Dynamics of changes in serum globulin levels ( Figure 2 ) convincingly shows that the use of conventional treatment with antibiotics exacerbates immune suppression and leads to the autoimmune process progression. So, IgA and IgM concentrations decreased even more (p=0.04), while IgG concentration increased by 30.8% (p=0.01) amounting to 18.7 g/l.
Endometrial thickness in the control group remained unchanged amounting to 5.2±1.2 mm. There was observed increase in midline echo indices in women receiving placenta hydrolysate and phlebotonic diosmin 600. At the end of the study its value equaled 7.1±0.6 mm, however, it failed to reach reliably normal level. Similar data are presented by authors in works [10, 12] , who have studied the effect of laennec on the endometrial thickness.
Treatment of the Hypoplastic Variant of Chronic Endometritis: Arguments Against Antibacterial Therapy In our opinion, there were positive changes in the blood flow under the influence of the therapy in the main group. Indeed, even with initially severe damage to the endometrium and the vascular wall in the hypoplastic variant of chronic endometritis we managed to visualize end branches of the spiral arteries in 32 patients (38.1%), this index remaining unchanged in all control patients (p>0.05).
Thus, the obtained results suggest the efficacy of conducted treatment (combined use of an immunomodulator and a phlebotonic).
Conclusion. The hypoplastic variant of chronic endometritis is an autoimmune process which is characterized by scarcity of the endometrial cell composition, on the one hand, and autoimmunization, on the other hand. Administration of antibiotics in the hypoplastic variant of chronic endometritis is inappropriate as antibiotics have no influence on the indices of local and systemic immunity, blood flow parameters and endometrial thickness, exacerbating, at the same time, autoimmunization of the organism.
Complex therapy of patients with the hypoplastic variant of chronic endometritis should include an immunomodulator (placenta hydrolysate laennec) and phlebotonics (diosmin 600) due to the positive effect of this therapy on the endometrial blood supply.
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